ZENOTECHPharmaceuticals
Zenotech Laboratories Ltd — PE Ratio & Valuation Analysis
₹34.29
-5.60%
Current P/E103.07xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E51.5x99.9% above avg
⚠️
224.4% Premium to Industry
ZENOTECH P/E 103.07x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.92 | ₹46 | 50.2x |
| 2024 | ₹1.36 | ₹72 | 52.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Zenotech Laboratories Ltd Valuation
Zenotech Laboratories Ltd (ZENOTECH) currently trades at 103.07x earnings. The Pharmaceuticals sector average PE is 31.77x. ZENOTECH commands a premium, reflecting high growth expectations. Historically, ZENOTECH has traded at an average PE of 51.5x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
4.81%
Dividend Yield
0.00%
More on Zenotech Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.